Cholesteryl ester oxidation products in atherosclerosis

Molecular Aspects of Medicine

Volumn 24, Issue 4-5, 2003, Pages 239-250

  Leitinger, Norbert ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Cholesteryl ester hydroperoxides; Core aldehydes; Inflammation; Lipid oxidation

Indexed keywords

9 OXONONANOYLCHOLESTEROL; ALCOHOL DERIVATIVE; ALDEHYDE; ARACHIDONATE 15 LIPOXYGENASE; ARYLDIALKYLPHOSPHATASE; CHOLESTEROL DERIVATIVE; CHOLESTEROL ESTER; HYDROPEROXIDE; LINOLEIC ACID; LIPOXYGENASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ATHEROGENESIS; ATHEROSCLEROSIS; BIODEGRADATION; CELL FUNCTION; CONFERENCE PAPER; ENZYME ACTIVATION; HUMAN; IN VIVO STUDY; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA; REDUCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0042170261     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(03)00019-0     Document Type: Conference Paper

References (77)

1. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101:1998;1581-1590.
2. Aviram M., Hardak E., Vaya J., Mahmood S., Milo S., Hoffman A., Billicke S., Draganov D., Rosenblat M. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation. 101:2000;2510-2517.
3. Baoutina A., Dean R.T., Jessup W. Macrophages can decrease the level of cholesteryl ester hydroperoxides in low density lipoprotein. J. Biol. Chem. 275:2000;1635-1644.
4. Baoutina A., Dean R.T., Jessup W. Antioxidant properties of macrophages toward low-density lipoprotein. Trends Cardiovasc. Med. 11:2001;1-7.
5. Belkner J., Wiesner R., Kuhn H., Lankin V.Z. The oxygenation of cholesterol esters by the reticulocyte lipoxygenase. FEBS Lett. 279:1991;110-114.
6. Belkner J., Wiesner R., Rathman J., Barnett J., Sigal E., Kuhn H. Oxygenation of lipoproteins by mammalian lipoxygenases. Eur. J. Biochem. 213:1993;251-261.
7. Belkner J., Stender H., Kuhn H. 15-Lipoxygenase preferentially oxygenates a subfraction of human low density lipoprotein. Adv. Exp. Med. Biol. 407:1997;465-469.
8. Belkner J., Stender H., Kuhn H. The rabbit 15-lipoxygenase preferentially oxygenates LDL cholesterol esters, and this reaction does not require vitamin E. J. Biol. Chem. 273:1998;23225-23232.
9. Belkner J., Stender H., Holzhutter H.G., Holm C., Kuhn H. Macrophage cholesteryl ester hydrolases and hormone-sensitive lipase prefer specifically oxidized cholesteryl esters as substrates over their non-oxidized counterparts. Biochem. J. 352(Pt 1):2000;125-133.
10. Belkner J., Stender H., Holzhutter H.G., Holm C., Kuhn H. Macrophage cholesteryl ester hydrolases and hormone-sensitive lipase prefer specifically oxidized cholesteryl esters as substrates over their non-oxidized counterparts. Biochem. J. 352(Pt 1):2000;125-133.
11. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
12. Bjornstedt M., Hamberg M., Kumar S., Xue J., Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J. Biol. Chem. 270:1995;11761-11764.
13. Bowry V.W., Stanley K.K., Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. USA. 89:1992;10316-10320.
14. Brown A.J., Dean R.T., Jessup W. Free and esterified oxysterol: formation during copper-oxidation of low density lipoprotein and uptake by macrophages. J. Lipid Res. 37:1996;320-335.
15. Brown A.J., Mander E.L., Gelissen I.C., Kritharides L., Dean R.T., Jessup W. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. J. Lipid Res. 41:2000;226-237.
16. Christison J.K., Rye K.A., Stocker R. Exchange of oxidized cholesteryl linoleate between LDL and HDL mediated by cholesteryl ester transfer protein. J. Lipid Res. 36:1995;2017-2026.
17. Christison J., Karjalainen A., Brauman J., Bygrave F., Stocker R. Rapid reduction and removal of HDL- but not LDL-associated cholesteryl ester hydroperoxides by rat liver perfused in situ. Biochem. J. 314(Pt 3):1996;739-742.
18. Esterbauer H., Jurgens G., Quehenberger O., Koller E. Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes. J. Lipid Res. 28:1987;495-509.
19. Ezaki M., Witztum J.L., Steinberg D. Lipoperoxides in LDL incubated with fibroblasts that overexpress 15-lipoxygenase. J. Lipid Res. 36:1995;1996-2004.
20. Felton C.V., Crook D., Davies M.J., Oliver M.F. Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler. Thromb. Vasc. Biol. 17:1997;1337-1345.
21. Fluiter K., Vietsch H., Biessen E.A., Kostner G.M., van Berkel T.J., Sattler W. Increased selective uptake in vivo and in vitro of oxidized cholesteryl esters from high-density lipoprotein by rat liver parenchymal cells. Biochem. J. 319(Pt 2):1996;471-476.
22. Folcik V.A., Nivar-Aristy R.A., Krajewski L.P., Cathcart M.K. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques. J. Clin. Invest. 96:1995;504-510.
23. Garner B., Waldeck A.R., Witting P.K., Rye K.A., Stocker R. Oxidation of high density lipoproteins. II. Evidence for direct reduction of lipid hydroperoxides by methionine residues of apolipoproteins AI and AII. J. Biol. Chem. 273:1998;6088-6095.
24. Garner B., Witting P.K., Waldeck A.R., Christison J.K., Raftery M., Stocker R. Oxidation of high density lipoproteins.I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol. J. Biol. Chem. 273:1998;6080-6087.
25. Glass C.K., Witztum J.L. Atherosclerosis. the road ahead. Cell. 104:2001;503-516.
26. Guyton J.R., Klemp K.F. Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. Arterioscler. Thromb. 14:1994;1305-1314.
27. Halliwell B. Free Radicals in Biology and Medicine. second ed. 1989;Clarendon Press, Oxford.
28. Hardwick S.J., Carpenter K.L., Law N.S., Van Der Veen C., Marchant C.E., Hird R., Mitchinson M.J. Toxicity of polyunsaturated fatty acid esters for human monocyte-macrophages: the anomalous behaviour of cholesteryl linolenate. Free Radic. Res. 26:1997;351-362.
29. Hegyi L., Skepper J.N., Cary N.R., Mitchinson M.J. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J. Pathol. 180:1996;423-429.
30. Hoppe G., Ravandi A., Herrera D., Kuksis A., Hoff H.F. Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions. J. Lipid Res. 38:1997;1347-1360.
31. Huber J., Boechzelt H., Karten B., Surboeck M., Bochkov V.N., Binder B.R., Sattler W., Leitinger N. Oxidized cholesteryl linoleates stimulate endothelial cells to bind monocytes via the extracellular signal-regulated kinase 1/2 pathway 1. Arterioscler. Thromb. Vasc. Biol. 22:2002;581-586.
32. Kamido H., Kuksis A., Marai L., Myher J.J. Identification of cholesterol-bound aldehydes in copper-oxidized low density lipoprotein. FEBS Lett. 304:1992;269-272.
33. Kamido H., Kuksis A., Marai L., Myher J.J. Identification of core aldehydes among in vitro peroxidation products of cholesteryl esters. Lipids. 28:1993;331-336.
34. Kamido H., Kuksis A., Marai L., Myher J.J. Lipid ester-bound aldehydes among copper-catalyzed peroxidation products of human plasma lipoproteins. J. Lipid Res. 36:1995;1876-1886.
35. Karten B., Boechzelt H., Abuja P.M., Mittelbach M., Oettl K., Sattler W. Femtomole analysis of 9-oxononanoyl cholesterol by high performance liquid chromatography. J. Lipid Res. 39:1998;1508-1519.
36. Karten B., Boechzelt H., Abuja P.M., Mittelbach M., Sattler W. Macrophage-enhanced formation of cholesteryl ester-core aldehydes during oxidation of low density lipoprotein. J. Lipid Res. 40:1999;1240-1253.
37. Kenar J.A., Havrilla C.M., Porter N.A., Guyton J.R., Brown S.A., Klemp K.F., Selinger E. Identification and quantification of regioisomeric cholesteryl linoleate hydroperoxides in oxidized human low density lipoprotein and high density lipoprotein. Chem. Res. Toxicol. 9:1996;737-744.
38. Kritharides L., Upston J., Jessup W., Dean R.T. Accumulation and metabolism of low density lipoprotein-derived cholesteryl linoleate hydroperoxide and hydroxide by macrophages. J. Lipid Res. 39:1998;2394-2405.
39. Kuhn H., Belkner J., Wiesner R., Schewe T., Lankin V.Z., Tikhaze A.K. Structure elucidation of oxygenated lipids in human atherosclerotic lesions. Eicosanoids. 5:1992;17-22.
40. Kuhn H., Belkner J., Suzuki H., Yamamoto S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J. Lipid Res. 35:1994;1749-1759.
41. Kuhn H., Belkner J., Zaiss S., Fahrenklemper T., Wohlfeil S. Involvement of 15-lipoxygenase in early stages of atherogenesis. J. Exp. Med. 179:1994;1903-1911.
42. Laplaud P.M., Dantoine T., Chapman M.J. Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses. Clin. Chem. Lab. Med. 36:1998;431-441.
43. 2+-catalysed oxidation. Biochem. J. 314(Pt 2):1996;577-585.
44. Letters J.M., Witting P.K., Christison J.K., Eriksson A.W., Pettersson K., Stocker R. Time-dependent changes to lipids and antioxidants in plasma and aortas of apolipoprotein E knockout mice. J. Lipid Res. 40:1999;1104-1112.
45. Lusis A.J. Atherosclerosis. Nature. 407:2000;233-241.
46. Mackness M.I., Durrington P.N. HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis. 115:1995;243-253.
47. Maehira F. Inhibitory effect of lipid hydroperoxide on cholesteryl esterases. Biochem. Mol. Biol. Int. 32:1994;221-231.
48. Mashima R., Yoshimura S., Yamamoto Y. Reduction of lipid hydroperoxides by apolipoprotein B-100. Biochem. Biophys. Res. Commun. 259:1999;185-189.
49. Mashima R., Onodera K., Yamamoto Y. Regioisomeric distribution of cholesteryl linoleate hydroperoxides and hydroxides in plasma from healthy humans provides evidence for free radical-mediated lipid peroxidation in vivo. J. Lipid Res. 41:2000;109-115.
50. Meyer D.F., Nealis A.S., Macphee C.H., Groot P.H., Suckling K.E., Bruckdorfer K.R., Perkins S.J. Time-course studies by synchrotron X-ray solution scattering of the structure of human low-density lipoprotein during Cu(2+)-induced oxidation in relation to changes in lipid composition. Biochem. J. 319(Pt 1):1996;217-227.
51. Nagata Y., Yamamoto Y., Niki E. Reaction of phosphatidylcholine hydroperoxide in human plasma: the role of peroxidase and lecithin:cholesterol acyltransferase. Arch. Biochem. Biophys. 329:1996;24-30.
52. Nishi K., Uno M., Fukuzawa K., Horiguchi H., Shinno K., Nagahiro S. Clinicopathological significance of lipid peroxidation in carotid plaques. Atherosclerosis. 160:2002;289-296.
53. Niu X., Zammit V., Upston J.M., Dean R.T., Stocker R. Coexistence of oxidized lipids and alpha-tocopherol in all lipoprotein density fractions isolated from advanced human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 19:1999;1708-1718.
54. Noguchi N., Gotoh N., Niki E. Dynamics of the oxidation of low density lipoprotein induced by free radicals. Biochim. Biophys. Acta. 1168:1993;348-357.
55. Noguchi N., Numano R., Kaneda H., Niki E. Oxidation of lipids in low density lipoprotein particles. Free Radic. Res. 29:1998;43-52.
56. Polidori M.C., Frei B., Rordorf G., Ogilvy C.S., Koroshetz W.J., Beal M.F. Increased levels of plasma cholesteryl ester hydroperoxides in patients with subarachnoid hemorrhage. Free Radic. Biol. Med. 23:1997;762-767.
57. Polidori M.C., Frei B., Cherubini A., Nelles G., Rordorf G., Keaney J.F. Jr., Schwamm L., Mecocci P., Koroshetz W.J., Beal M.F. Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic. Biol. Med. 25:1998;561-567.
58. Porter N.A., Caldwell S.E., Mills K.A. Mechanisms of free radical oxidation of unsaturated lipids. Lipids. 30:1995;277-290.
59. Pushpa-Rekha T.R., Burdsall A.L., Oleksa L.M., Chisolm G.M., Driscoll D.M. Rat phospholipid-hydroperoxide glutathione peroxidase. cDNA cloning and identification of multiple transcription and translation start sites. J. Biol. Chem. 270:1995;26993-26999.
60. Reid V.C., Brabbs C.E., Mitchinson M.J. Cellular damage in mouse peritoneal macrophages exposed to cholesteryl linoleate. Atherosclerosis. 92:1992;251-260.
61. Sattler W., Stocker R. Greater selective uptake by Hep G2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters. Biochem. J. 294(Pt 3):1993;771-778.
62. Sattler W., Maiorino M., Stocker R. Reduction of HDL- and LDL-associated cholesterylester and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and Ebselen (PZ 51). Arch. Biochem. Biophys. 309:1994;214-221.
63. Sattler W., Christison J., Stocker R. Cholesterylester hydroperoxide reducing activity associated with isolated high- and low-density lipoproteins. Free Radic. Biol. Med. 18:1995;421-429.
64. Srivastava S., Liu S.Q., Conklin D.J., Zacarias A., Srivastava S.K., Bhatnagar A. Involvement of aldose reductase in the metabolism of atherogenic aldehydes. Chemico-Biol. Interact. 130:2001;563-571.
65. Steinbrecher U.P., Parthasarathy S., Leake D.S., Witztum J.L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA. 81:1984;3883-3887.
66. Steinbrecher U.P., Lougheed M., Kwan W.C., Dirks M. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation. J. Biol. Chem. 264:1989;15216-15223.
67. Stocker R., Bowry V.W., Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc. Natl. Acad. Sci. USA. 88:1991;1646-1650.
68. Suarna C., Dean R.T., May J., Stocker R. Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of alpha-tocopherol and ascorbate. Arterioscler. Thromb. Vasc. Biol. 15:1995;1616-1624.
69. Terao J. Reactions of lipid hydroperoxides. Pelfrey C. Membrane-Lipid Oxidation. 1990;219-238 CRC Press, Boca Raton.
70. Thomas J.P., Geiger P.G., Maiorino M., Ursini F., Girotti A.W. Enzymatic reduction of phospholipid and cholesterol hydroperoxides in artificial bilayers and lipoproteins. Biochim. Biophys. Acta. 1045:1990;252-260.
71. Thomas J.P., Kalyanaraman B., Girotti A.W. Involvement of preexisting lipid hydroperoxides in Cu(2+)-stimulated oxidation of low-density lipoprotein. Arch. Biochem. Biophys. 315:1994;244-254.
72. Upston J.M., Neuzil J., Stocker R. Oxidation of LDL by recombinant human 15-lipoxygenase: evidence for alpha-tocopherol-dependent oxidation of esterified core and surface lipids. J. Lipid Res. 37:1996;2650-2661.
73. Upston J.M., Neuzil J., Witting P.K., Alleva R., Stocker R. Oxidation of free fatty acids in low density lipoprotein by 15-lipoxygenase stimulates nonenzymic, alpha-tocopherol-mediated peroxidation of cholesteryl esters. J. Biol. Chem. 272:1997;30067-30074.
74. Upston J.M., Terentis A.C., Morris K., Keaney J.F. Jr., Stocker R. Oxidized lipid accumulates in the presence of alpha-tocopherol in atherosclerosis. Biochem. J. 363:2002;753-760.
75. Van Heek M., Schmitt D., Toren P., Cathcart M.K., DiCorleto P.E. Cholesteryl hydroperoxyoctadecadienoate from oxidized low density lipoprotein inactivates platelet-derived growth factor. J. Biol. Chem. 273:1998;19405-19410.
76. Yamamoto Y., Niki E. Presence of cholesteryl ester hydroperoxide in human blood plasma. Biochem. Biophys. Res. Commun. 165:1989;988-993.
77. Yin H., Havrilla C.M., Morrow J.D., Porter N.A. Formation of isoprostane bicyclic endoperoxides from the autoxidation of cholesteryl arachidonate. J. Am. Chem. Soc. 124:2002;7745-7754.